Document Detail


Reversibility of cytotoxic edema in tacrolimus leukoencephalopathy.
MedLine Citation:
PMID:  20933182     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Posterior reversible encephalopathy syndrome, a serious neurotoxicity, may develop rarely in patients receiving tacrolimus. Because the underlying etiology of posterior reversible encephalopathy syndrome is vasogenic edema, it is generally accepted to be a reversible neurologic condition. Cranial magnetic resonance imaging techniques enable detection of the type of edema, and they are widely used in the differential diagnosis and prognostic prediction of posterior reversible encephalopathy syndrome. Presented here is a case of posterior reversible encephalopathy syndrome in which the patient recovered completely, despite radiologic findings indicating the coexistence of vasogenic and cytotoxic edema secondary to tacrolimus therapy after liver transplantation.
Authors:
Sanem Yilmaz; Sarenur Gokben; Cigdem Arikan; Cem Calli; Gul Serdaroglu
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric neurology     Volume:  43     ISSN:  1873-5150     ISO Abbreviation:  Pediatr. Neurol.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-11     Completed Date:  2011-02-10     Revised Date:  2011-03-15    
Medline Journal Info:
Nlm Unique ID:  8508183     Medline TA:  Pediatr Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  359-62     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Affiliation:
Division of Child Neurology, Department of Pediatrics, Ege University, Bornova-Izmir, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain Edema / chemically induced*
Child
Diffusion Magnetic Resonance Imaging / methods
Hepatitis B, Chronic / complications
Humans
Immunosuppressive Agents / adverse effects*
Leukoencephalopathies / chemically induced*,  pathology
Liver Failure, Acute / drug therapy,  etiology,  surgery
Liver Transplantation / methods
Male
Tacrolimus / adverse effects*
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; 109581-93-3/Tacrolimus
Comments/Corrections
Comment In:
Pediatr Neurol. 2011 Mar;44(3):236; author reply 236   [PMID:  21310344 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nocturnal choking episodes: under-recognized and misdiagnosed.
Next Document:  A novel missense mutation in a neonate with nonketotic hyperglycinemia.